FERRARI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 36.913
EU - Europa 9.967
AS - Asia 5.962
SA - Sud America 96
AF - Africa 36
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 14
Totale 53.015
Nazione #
US - Stati Uniti d'America 36.852
CN - Cina 3.312
IT - Italia 2.948
UA - Ucraina 2.393
TR - Turchia 1.435
DE - Germania 1.287
GB - Regno Unito 969
SG - Singapore 731
SE - Svezia 697
FI - Finlandia 534
PL - Polonia 485
FR - Francia 214
VN - Vietnam 132
ID - Indonesia 108
BE - Belgio 89
IN - India 62
CZ - Repubblica Ceca 48
RU - Federazione Russa 48
BR - Brasile 47
ES - Italia 41
CA - Canada 40
NL - Olanda 36
HK - Hong Kong 33
CH - Svizzera 28
IE - Irlanda 23
KR - Corea 22
CO - Colombia 19
AU - Australia 18
RO - Romania 17
LK - Sri Lanka 16
EG - Egitto 14
IR - Iran 14
EU - Europa 12
HR - Croazia 12
MX - Messico 12
PK - Pakistan 11
AL - Albania 10
HU - Ungheria 10
PT - Portogallo 10
TW - Taiwan 10
CL - Cile 9
IL - Israele 9
JP - Giappone 9
NZ - Nuova Zelanda 9
EC - Ecuador 8
GE - Georgia 8
NO - Norvegia 8
RS - Serbia 8
BG - Bulgaria 7
DK - Danimarca 7
GR - Grecia 7
IQ - Iraq 7
TH - Thailandia 7
AR - Argentina 6
AT - Austria 6
LT - Lituania 6
PH - Filippine 6
MY - Malesia 5
ZA - Sudafrica 5
MK - Macedonia 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
YE - Yemen 4
BO - Bolivia 3
CU - Cuba 3
MD - Moldavia 3
PE - Perù 3
SA - Arabia Saudita 3
AM - Armenia 2
CM - Camerun 2
CY - Cipro 2
ET - Etiopia 2
GH - Ghana 2
JO - Giordania 2
KW - Kuwait 2
MA - Marocco 2
NI - Nicaragua 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
EE - Estonia 1
GL - Groenlandia 1
HN - Honduras 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MM - Myanmar 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
RE - Reunion 1
Totale 53.012
Città #
Fairfield 5.337
Woodbridge 5.000
Houston 3.146
Jacksonville 2.703
Ashburn 2.621
Chandler 2.389
Ann Arbor 2.106
Seattle 2.089
Wilmington 1.864
Cambridge 1.776
Izmir 952
Nanjing 867
Princeton 751
Beijing 560
San Diego 477
Warsaw 471
Singapore 411
Boardman 406
Milan 316
Ferrara 301
Shenyang 258
Shanghai 245
Nanchang 244
New York 230
Falls Church 155
Hebei 147
Changsha 143
Jiaxing 143
Bremen 134
Redwood City 132
Rome 132
Tianjin 129
San Mateo 121
Mountain View 119
Dong Ket 118
Addison 107
Jakarta 97
Jinan 96
London 96
Brussels 87
Norwalk 82
Zhengzhou 81
Dearborn 80
Ningbo 64
Kunming 62
Washington 59
Des Moines 53
Orange 51
Los Angeles 50
Naples 48
Philadelphia 48
Verona 48
Taizhou 45
Bologna 43
Napoli 43
Guangzhou 39
Helsinki 38
Indiana 38
Tappahannock 35
Chicago 34
Turin 29
Auburn Hills 28
Hong Kong 27
Redmond 27
Hangzhou 26
Changchun 24
Florence 24
Brno 23
Kilburn 23
Lanzhou 22
Padova 22
Bari 21
Augusta 18
Palermo 18
Hounslow 17
Leawood 17
Olomouc 17
Torino 16
Genova 14
Munich 14
Pisa 14
San Francisco 14
Dublin 12
Yellow Springs 12
Cagliari 11
Haikou 11
Hefei 11
Monmouth Junction 11
Catania 10
Hamburg 10
Lappeenranta 10
Montréal 10
Braunschweig 9
Brescia 9
Hanoi 9
Mumbai 9
Paris 9
Wuhan 9
Frankfurt am Main 8
Salerno 8
Totale 39.150
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.668
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 293
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 254
Il lungo cammino degli inibitori dell'enzima di conversione dell'angiotensina nella lotta per le malattie cardiovascolari 223
Valutazione ecocardiografica dell'insufficienza mitralica nella prospettiva della riparazione valvolare 210
null 206
Scompenso cardiaco con frazione di eiezione intermedia. Alla ricerca della Terra di Mezzo? 204
The Notch pathway: a novel therapeutic target for cardiovascular diseases? 193
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 183
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis 180
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study 179
Left ventricular ejection fraction and heart failure: an indissoluble marriage? 177
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain 169
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 161
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease 157
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) 157
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion. 154
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 154
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 154
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 153
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 147
Heart failure with preserved ejection fraction: uncertainties and dilemmas 147
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 145
17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells 145
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 143
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 142
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 141
The role of Notch pathway in cardiovascular diseases. 141
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 140
Cardiac resynchronization therapy guided by multimodality cardiac imaging 140
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors 140
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 139
CANCER THERAPY-INDUCED CARDIOTOXICITY: ROLE OF ULTRASOUND DEFORMATION IMAGING AS AN AID TO EARLY DIAGNOSIS 137
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 137
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 136
2013 ESC guidelines on the management of stable coronary artery disease 133
Uric acid and coronary artery disease: An elusive link deserving further attention 133
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 131
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 131
Poor response to clopidogrel: current and future options for its management 130
Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. 129
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 129
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 128
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 128
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 127
Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry 126
Individualized angiotensin-converting enzyme (ACE)-inhibitor therapy in stable coronary artery disease based on clinical and pharmacogenetic determinants: The PERindopril GENEtic (PERGENE) risk model 126
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 126
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 125
KRIT1 deficiency promotes aortic endothelial dysfunction 125
Coronary artery disease: Use of ACE inhibitors in stable CAD - What is the truth? 124
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions 124
Reperfusion Damage - A Story of Success, Failure, and Hope 124
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 123
Can we improve myocardial protection during ischaemic injury? 123
Cardiovascular complications of radiation therapy for thoracic malignancies: The role for non-invasive imaging for detection of cardiovascular disease 122
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 121
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 120
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study 120
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 119
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 119
The in vitro effects of verbascoside on human platelet aggregation 118
Not just numbers, but years of science: Putting the ACE inhibitor—ARB meta-analyses into context 117
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 117
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 117
RESTING HEART RATE IN CARDIOVASCULAR DISEASE 116
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - Results from EUROPA 115
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 115
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. 114
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis 114
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 114
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials 114
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 114
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 114
Is stunning an important component of preconditioning? 113
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 113
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 113
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 113
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 113
Angiotensin-converting enzyme inhibition in cardiovascular disease evidence with perindopril 112
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 112
Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using doppler measures of myocardial strain. 112
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study 112
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 112
Long-Term Effect of Perindopril on Coronary Atherosclerosis Progression (from the PERindopril's Prospective Effect on Coronary aTherosclerosis by Angiography and IntraVascular Ultrasound Evaluation [PERSPECTIVE] Study) 111
Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. 111
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 111
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 111
International cooperation in healthcare: Model of IRCCS Policlinico San Donato and Bambini Cardiopatici nel Mondo Association for congenital heart diseases 111
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 111
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? 110
Radiofrequency ablation of atrial fibrillation: is the persistence of all intraprocedural targets necessary for long-term maintenance of sinus rhythm? 110
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease 110
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression 110
Noncontact Mapping of Left Ventricle during CRT Implant 110
Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems: Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure 110
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 110
A Strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. 109
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 109
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke) 109
Totale 15.002
Categoria #
all - tutte 219.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.741
Totale 223.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012.211 1.880 441 464 1.743 857 1.426 1.121 1.276 1.024 1.199 488 292
2020/20218.376 681 744 515 930 363 913 316 1.061 254 1.119 996 484
2021/20227.070 323 777 577 273 413 357 359 366 296 505 753 2.071
2022/20236.078 715 190 226 668 982 900 219 634 840 60 397 247
2023/20243.481 359 433 210 120 238 490 152 206 77 160 153 883
2024/2025250 250 0 0 0 0 0 0 0 0 0 0 0
Totale 53.984